Zura Bio
Someit Sidhu is the Founder, CEO, and Board Member of Zura Bio Limited. Previously, Someit was the Co-Founder of Pathios Therapeutics and Izana Bioscience, focusing on bringing innovative science to market. Someit also served as the CEO & Chairman of JATT Acquisition Corp. With a medical background from University of Oxford, Someit has experience as a Medical Doctor at University Hospital Birmingham and as an Associate at McKinsey & Company.
This person is not in any offices
Zura Bio
1 followers
Zura Bio is a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders. Currently, Zura Bio is developing three assets which have completed phase 1/1b studies and are Phase 2 ready. The company is developing a portfolio of therapeutic indications for tibulizumab (ZB-106), torudokimab (ZB-880), and ZB-168 with a goal of demonstrating their efficacy, safety, and dosing convenience in immune and inflammatory disorders. Zura Bio is headquartered in Henderson, NV with team members in the UK and USA.